Co-Diagnostics, Inc. (CODX) vs NeuroSense Therapeutics Ltd. (NRSN)

A side-by-side comparison of Co-Diagnostics, Inc. and NeuroSense Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CODX

Co-Diagnostics, Inc.

$7M

$1.12HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT

NRSN

NeuroSense Therapeutics Ltd.

$7M

$3.93HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT

Total return — CODX vs NRSN

growth of $100 · dividends reinvested · last 5y

CODX -99.6% (-66.4%/yr)NRSN -95.0% (-45.1%/yr)NRSN compounded faster over this window

Log scale — wide-divergence pair

CODX NRSN

CODX vs NRSN: by the numbers

•CODX is the larger company ($7M vs $7M market cap).
•Both run net losses; NRSN's is the smaller (0.00% vs -6523.04% net margin).

Metrics side by side

Valuation

Metric	CODX	NRSN
P/S ratio	9.66	N/A
P/B ratio	0.55	N/A

Profitability

Metric	CODX	NRSN
Gross margin	64.28%	0.00%
Operating margin	-5025.53%	0.00%
Net margin	-6523.04%	0.00%
ROE	-370.16%	N/A
ROIC	-219.15%	N/A

Growth (annualized)

Metric	CODX	NRSN
Revenue CAGR (5Y)	-62.43%	N/A
Total return CAGR (5Y)	-66.53%	N/A

Go deeper

Full CODX analysis Full NRSN analysis Interactive comparison tool

Dig into the metrics

Co-Diagnostics ROE NeuroSense Therapeutics ROE Co-Diagnostics operating margin NeuroSense Therapeutics operating margin Co-Diagnostics revenue growth NeuroSense Therapeutics revenue growth Co-Diagnostics free cash flow NeuroSense Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.